• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

儿科口服阿替洛尔制剂的首次开发、优化和稳定性控制。

First Development, Optimization, and Stability Control of a Pediatric Oral Atenolol Formulation.

机构信息

Planta piloto de Producción de Medicamentos, Facultad de Ciencias Bioquímicas y Farmacéuticas, Universidad Nacional de Rosario, Suipacha 570, 2000, Rosario, Argentina.

Área Análisis de Medicamentos, Departamento Química Orgánica, Facultad de Ciencias Bioquímicas y Farmacéuticas, Universidad Nacional de Rosario, Suipacha 570, 2000, Rosario, Argentina.

出版信息

AAPS PharmSciTech. 2018 May;19(4):1781-1788. doi: 10.1208/s12249-018-0992-5. Epub 2018 Mar 30.

DOI:10.1208/s12249-018-0992-5
PMID:29603083
Abstract

Liquid formulations can be used in children of different ages by varying the volume of the administered dose in order to ensure an exact dosage. The aim of this work was to develop and to optimize a safe liquid atenolol formulation and to carry out the corresponding chemical and microbiological stability studies. A Plackett-Burman design was used to determine the factors that could be critical in the development of the formulations, and a central composite design was used to determine the optimal working conditions. As a result of these analyses, three formulations were selected and their stability studied in three storage conditions, 4, 25, and 40°C. After 6 months of stability testing, the optimal systems showed no pH change or atenolol loss; however, only glycerin-based formulations showed no microbial development. These systems, employing excipients in a range that the EMA has recommended, showed chemical and microbiological stability for at least 6 months even at the worst storage conditions.

摘要

液体剂型可通过改变给药剂量的体积来用于不同年龄段的儿童,以确保准确的剂量。本工作的目的是开发和优化安全的液体阿替洛尔制剂,并进行相应的化学和微生物稳定性研究。采用 Plackett-Burman 设计来确定可能对制剂开发至关重要的因素,采用中心复合设计来确定最佳工作条件。通过这些分析,选择了三种制剂,并在 4、25 和 40°C 三种储存条件下研究其稳定性。经过 6 个月的稳定性测试,最佳系统没有显示 pH 值变化或阿替洛尔损失;然而,只有基于甘油的制剂没有显示微生物生长。这些系统使用 EMA 推荐的范围内的赋形剂,即使在最恶劣的储存条件下,也至少能保持 6 个月的化学和微生物稳定性。

相似文献

1
First Development, Optimization, and Stability Control of a Pediatric Oral Atenolol Formulation.儿科口服阿替洛尔制剂的首次开发、优化和稳定性控制。
AAPS PharmSciTech. 2018 May;19(4):1781-1788. doi: 10.1208/s12249-018-0992-5. Epub 2018 Mar 30.
2
Development of a novel physico-chemically and microbiologically stable oral solution of flecainide for pediatrics.开发一种新型物理化学和微生物稳定的氟卡尼口服液,用于儿科。
Pharm Dev Technol. 2018 Dec;23(10):978-985. doi: 10.1080/10837450.2016.1238484. Epub 2016 Oct 26.
3
A High-Demanding Strategy to Ensure the Highest Quality Standards of Oral Liquid Individualized Medicines for Pediatric Use.确保儿科用口服液体制剂达到最高质量标准的高要求策略。
AAPS PharmSciTech. 2019 Jun 3;20(5):208. doi: 10.1208/s12249-019-1432-x.
4
Physicochemical and microbiological stability of two news oral liquid formulations of clonidine hydrochloride for pediatric patients.盐酸可乐定两种新口服液体制剂用于儿科患者的理化和微生物稳定性。
Pharm Dev Technol. 2019 Apr;24(4):465-478. doi: 10.1080/10837450.2018.1514520. Epub 2018 Nov 19.
5
Formulation development and optimization: Encapsulated system of Atenolol and Glyburide.制剂研发与优化:阿替洛尔和格列本脲的包封系统
Pak J Pharm Sci. 2016 Mar;29(2):569-77.
6
Evaluation of microwave oven heating for prediction of drug-excipient compatibilities and accelerated stability studies.评价微波炉加热在预测药物-赋形剂相容性和加速稳定性研究中的应用。
Int J Pharm. 2015 May 15;485(1-2):97-107. doi: 10.1016/j.ijpharm.2015.02.071. Epub 2015 Mar 3.
7
Formulation and stability study of hydroxychloroquine sulfate oral suspensions.硫酸羟氯喹口服混悬剂的制备及稳定性研究。
Pharm Dev Technol. 2021 Mar;26(3):328-334. doi: 10.1080/10837450.2021.1871918. Epub 2021 Jan 17.
8
Stability considerations in liquid dosage forms extemporaneously prepared from commercially available products.由市售产品临时配制的液体制剂的稳定性考量。
J Pharm Pharm Sci. 2006;9(3):398-426.
9
Microbiological quality of pediatric oral liquid formulations.儿科口服液体制剂的微生物质量
Farm Hosp. 2016 Sep 1;40(5):427-35. doi: 10.7399/fh.2016.40.5.10541.
10
Stability of atenolol in an extemporaneously compounded oral liquid.阿替洛尔在临时配制口服液中的稳定性。
Am J Hosp Pharm. 1994 Feb 15;51(4):508-11.

引用本文的文献

1
Flexible New Dosage Forms Containing Carvedilol for the Treatment of Patients with Cardiovascular Disorders: Development, Stability, Palatability, and Microbiological Studies.含有卡维地洛的新型灵活制剂用于治疗心血管疾病患者:开发、稳定性、口感和微生物学研究。
AAPS PharmSciTech. 2023 Jul 27;24(6):159. doi: 10.1208/s12249-023-02612-w.
2
Miconazole Nitrate Microparticles in Lidocaine Loaded Films as a Treatment for Oropharyngeal Candidiasis.载利多卡因薄膜中的硝酸咪康唑微粒用于治疗口腔念珠菌病
Materials (Basel). 2023 May 7;16(9):3586. doi: 10.3390/ma16093586.
3
Stability of Oral Liquid Dosage Forms in Pediatric Cardiology: A Prerequisite for Patient's Safety-A Narrative Review.
儿科心脏病学中口服液体制剂的稳定性:患者安全的先决条件——一篇叙述性综述。
Pharmaceutics. 2023 Apr 21;15(4):1306. doi: 10.3390/pharmaceutics15041306.